1222 results AFM review indicates lack of transparency in use of alternative performance measures by Dutch issuers AFM sets out the findings of its review of the use of alternative performance measures in financial reporting and concludes that Dutch issuers often fall short of the required level of transparency when reporting their alternative performance measures. District Court ruled on the recognition of the res judicata effect of a Turkish judgment and dismissed an antitrust follow on damages claim regarding the cathode-ray tube markets The District Court of Oost-Brabant recognized the res judicata effect of a Turkish court of appeal judgment, in which the Turkish court had dismissed antitrust damages claims brought by Vestel against Philips, Samsung, LGE, Technicolor, TTD and TDP. Stibbe advises Palex Medical Stibbe is advising Palex Medical, a Spain-based company specialising in high value-added MedTech equipment and solutions, on its planned acquisition of Duomed, a fast-growing European MedTech distributor. Stibbe advises GRW on the acquisition of Van Hool’s industrial vehicle division Stibbe advised GRW, the South African tanker and trailer manufacturer allied with Schmitz Cargobull, on acquiring the industrial vehicle division of Van Hool, following the latter’s declaration of bankruptcy. Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all? The Foreign Subsidies Regulation’s initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commission’s initial enforcement actions appear to be targeting Chinese subsidies. Aansprakelijkheidsstelling bij duurzaamheid: een ritselende revolutie In het Transformation Forums Magazine gaat Branda Katan in op de effectiviteit van het aansprakelijk stellen van bedrijven voor de impact die ze hebben op mensenrechten, milieu en klimaat, oftewel op duurzaamheid. WAMCA: massaschadeclaims in Nederland In deze Stibbe Legal Insights bespreken Branda Katan en Jeroen Kortmann massaschadeclaims, waarmee stichtingen namens een grote groep gedupeerde consumenten schadevergoeding kunnen eisen. Stibbe advises the SCHMID Group Stibbe, together with Gleiss Lutz, has advised the SCHMID Group on its business combination with Pegasus Digital Mobility Acquisition Corp. and listing on NASDAQ. Environmental and Human Rights Due Diligence in Action: A Brazilian-European Perspective Participate in our webinar in collaboration with Brazilian law firm Pinheiro Neto. This session aims to clarify the complexities of EU sustainability legislation and its implications for companies operating in Brazil. Tax Alert: New Dutch government announces tax measures On Thursday 16 May 2024, the four political parties (forming the new Dutch government) which have been negotiating for the past several months came to an agreement (Hoofdlijnenakkoord 2024) in which their plans and policies are laid down. E-book: 'Sustainable Finance in Europe' Stibbe lawyers Marieke Driessen, Loes van Dijk and Ingrid van der Klooster contributed to the book 'Sustainable Finance in Europe' which was recently published. Listing Act: Expanded exemptions for managers to trade during closed periods In October 2024, the European Council adopted the EU Listing Act, a legislative package that includes changes to the Market Abuse Regulation. We discuss the expanded exemptions to the prohibition of PDMRs carrying out transactions during a closed period. Third time lucky: Intel wins loyalty rebate battle at EU top court The European Court of Justice has upheld the annulment of Intel’s EUR 1.06 billion fine for abuse of dominance. The judgment provides guidance on how to assess the anti-competitiveness of loyalty rebates. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. Stibbe advised LEG Immobilien SE (LEG) Stibbe advised LEG Immobilien SE (LEG) on the acquisition of Brack Capital Properties N.V. Pagination Previous page Page 26 Current page 27 Page 28 Page 29 Next page
AFM review indicates lack of transparency in use of alternative performance measures by Dutch issuers AFM sets out the findings of its review of the use of alternative performance measures in financial reporting and concludes that Dutch issuers often fall short of the required level of transparency when reporting their alternative performance measures.
District Court ruled on the recognition of the res judicata effect of a Turkish judgment and dismissed an antitrust follow on damages claim regarding the cathode-ray tube markets The District Court of Oost-Brabant recognized the res judicata effect of a Turkish court of appeal judgment, in which the Turkish court had dismissed antitrust damages claims brought by Vestel against Philips, Samsung, LGE, Technicolor, TTD and TDP.
Stibbe advises Palex Medical Stibbe is advising Palex Medical, a Spain-based company specialising in high value-added MedTech equipment and solutions, on its planned acquisition of Duomed, a fast-growing European MedTech distributor.
Stibbe advises GRW on the acquisition of Van Hool’s industrial vehicle division Stibbe advised GRW, the South African tanker and trailer manufacturer allied with Schmitz Cargobull, on acquiring the industrial vehicle division of Van Hool, following the latter’s declaration of bankruptcy.
Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all?
The Foreign Subsidies Regulation’s initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commission’s initial enforcement actions appear to be targeting Chinese subsidies.
Aansprakelijkheidsstelling bij duurzaamheid: een ritselende revolutie In het Transformation Forums Magazine gaat Branda Katan in op de effectiviteit van het aansprakelijk stellen van bedrijven voor de impact die ze hebben op mensenrechten, milieu en klimaat, oftewel op duurzaamheid.
WAMCA: massaschadeclaims in Nederland In deze Stibbe Legal Insights bespreken Branda Katan en Jeroen Kortmann massaschadeclaims, waarmee stichtingen namens een grote groep gedupeerde consumenten schadevergoeding kunnen eisen.
Stibbe advises the SCHMID Group Stibbe, together with Gleiss Lutz, has advised the SCHMID Group on its business combination with Pegasus Digital Mobility Acquisition Corp. and listing on NASDAQ.
Environmental and Human Rights Due Diligence in Action: A Brazilian-European Perspective Participate in our webinar in collaboration with Brazilian law firm Pinheiro Neto. This session aims to clarify the complexities of EU sustainability legislation and its implications for companies operating in Brazil.
Tax Alert: New Dutch government announces tax measures On Thursday 16 May 2024, the four political parties (forming the new Dutch government) which have been negotiating for the past several months came to an agreement (Hoofdlijnenakkoord 2024) in which their plans and policies are laid down.
E-book: 'Sustainable Finance in Europe' Stibbe lawyers Marieke Driessen, Loes van Dijk and Ingrid van der Klooster contributed to the book 'Sustainable Finance in Europe' which was recently published.
Listing Act: Expanded exemptions for managers to trade during closed periods In October 2024, the European Council adopted the EU Listing Act, a legislative package that includes changes to the Market Abuse Regulation. We discuss the expanded exemptions to the prohibition of PDMRs carrying out transactions during a closed period.
Third time lucky: Intel wins loyalty rebate battle at EU top court The European Court of Justice has upheld the annulment of Intel’s EUR 1.06 billion fine for abuse of dominance. The judgment provides guidance on how to assess the anti-competitiveness of loyalty rebates.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
Stibbe advised LEG Immobilien SE (LEG) Stibbe advised LEG Immobilien SE (LEG) on the acquisition of Brack Capital Properties N.V.